Literature DB >> 20816747

Kinetic evidence that allosteric activation of antithrombin by heparin is mediated by two sequential conformational changes.

Sophia Schedin-Weiss1, Benjamin Richard, Steven T Olson.   

Abstract

The serpin, antithrombin, requires allosteric activation by a sequence-specific pentasaccharide unit of heparin or heparan sulfate glycosaminoglycans to function as an anticoagulant regulator of blood clotting proteases. Surprisingly, X-ray structures have shown that the pentasaccharide produces similar induced-fit changes in the heparin binding site of native and latent antithrombin despite large differences in the heparin affinity and global conformation of these two forms. Here we present kinetic evidence for similar induced-fit mechanisms of pentasaccharide binding to native and latent antithrombins and kinetic simulations which together support a three-step mechanism of allosteric activation of native antithrombin involving two successive conformational changes. Equilibrium binding studies of pentasaccharide interactions with native and latent antithrombins and the salt dependence of these interactions suggest that each conformational change is associated with distinct spectroscopic changes and is driven by a progressively better fit of the pentasaccharide in the binding site. The observation that variant antithrombins that cannot undergo the second conformational change bind the pentasaccharide like latent antithrombin and are partially activated suggests that both conformational changes contribute to allosteric activation, in agreement with a recently proposed model of allosteric activation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20816747      PMCID: PMC2965262          DOI: 10.1016/j.abb.2010.08.021

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  38 in total

1.  Deletion of P1 arginine in a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhances heparin affinity and is associated with early onset thrombosis.

Authors:  Srikumar M Raja; Neetu Chhablani; Richard Swanson; Elizabeth Thompson; Mike Laffan; David A Lane; Steven T Olson
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

Review 2.  Serpin structure, mechanism, and function.

Authors:  Peter G W Gettins
Journal:  Chem Rev       Date:  2002-12       Impact factor: 60.622

3.  A regulatory hydrophobic area in the flexible joint region of plasminogen activator inhibitor-1, defined with fluorescent activity-neutralizing ligands. Ligand-induced serpin polymerization.

Authors:  R Egelund; A P Einholm; K E Pedersen; R W Nielsen; A Christensen; J Deinum; P A Andreasen
Journal:  J Biol Chem       Date:  2001-01-25       Impact factor: 5.157

4.  Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.

Authors:  Y J Chuang; R Swanson; S M Raja; S T Olson
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

Review 5.  Identification of critical molecular interactions mediating heparin activation of antithrombin: implications for the design of improved heparin anticoagulants.

Authors:  Steven T Olson; Ingemar Björk; Susan C Bock
Journal:  Trends Cardiovasc Med       Date:  2002-07       Impact factor: 6.677

6.  Helix D elongation and allosteric activation of antithrombin.

Authors:  Klara J Belzar; Aiwu Zhou; Robin W Carrell; Peter G W Gettins; James A Huntington
Journal:  J Biol Chem       Date:  2001-12-10       Impact factor: 5.157

7.  Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa.

Authors:  A Futamura; P G Gettins
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

8.  Molecular basis of factor IXa recognition by heparin-activated antithrombin revealed by a 1.7-A structure of the ternary complex.

Authors:  Daniel J D Johnson; Jonathan Langdown; James A Huntington
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  Heparin and calcium ions dramatically enhance antithrombin reactivity with factor IXa by generating new interaction exosites.

Authors:  Tina Bedsted; Richard Swanson; Yung-Jen Chuang; Paul E Bock; Ingemar Björk; Steven T Olson
Journal:  Biochemistry       Date:  2003-07-15       Impact factor: 3.162

Review 10.  1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site.

Authors:  Maurice Petitou; Benito Casu; Ulf Lindahl
Journal:  Biochimie       Date:  2003 Jan-Feb       Impact factor: 4.079

View more
  6 in total

Review 1.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

2.  Saturation Mutagenesis of the Antithrombin Reactive Center Loop P14 Residue Supports a Three-step Mechanism of Heparin Allosteric Activation Involving Intermediate and Fully Activated States.

Authors:  Ryan Roth; Richard Swanson; Gonzalo Izaguirre; Susan C Bock; Peter G W Gettins; Steven T Olson
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

3.  Molecular basis of glycosaminoglycan heparin binding to the chemokine CXCL1 dimer.

Authors:  Krishna Mohan Poluri; Prem Raj B Joseph; Kirti V Sawant; Krishna Rajarathnam
Journal:  J Biol Chem       Date:  2013-07-17       Impact factor: 5.157

4.  Allosteric modulation of hormone release from thyroxine and corticosteroid-binding globulins.

Authors:  Xiaoqiang Qi; François Loiseau; Wee Lee Chan; Yahui Yan; Zhenquan Wei; Lech-Gustav Milroy; Rebecca M Myers; Steven V Ley; Randy J Read; Robin W Carrell; Aiwu Zhou
Journal:  J Biol Chem       Date:  2011-02-16       Impact factor: 5.157

Review 5.  Optimizing transfusion strategies in damage control resuscitation: current insights.

Authors:  Timothy H Pohlman; Alison M Fecher; Cecivon Arreola-Garcia
Journal:  J Blood Med       Date:  2018-08-20

6.  Increased N-glycosylation efficiency by generation of an aromatic sequon on N135 of antithrombin.

Authors:  Sonia Aguila; Irene Martínez-Martínez; Gilda Dichiara; Ricardo Gutiérrez-Gallego; José Navarro-Fernández; Vicente Vicente; Javier Corral
Journal:  PLoS One       Date:  2014-12-08       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.